Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Industrial Research Assistance Program – Contributions to Firms

IRegained Inc.

$50,000.00

Healthcare Economic Case Study for IRegained MyHand System

EF 2021-22 · 2021-05-03

Résumé
The IRegained MyHand System is planned to be exported to the USA in Q2 of 2022. In preparation for this market launch, IRegained is completing a health care economics value proposition model and whitepaper to establish a clear reimbursement pathway through the payors such as insurance companies, Medicare, Medicaid etc. for customer adoption.
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Sudbury|Sudbury, Ontario, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
737051524
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

Tel que publié

Agreement End Date
2022-03-15
Agreement Number
971563
Agreement Start Date
2021-05-03
Agreement Title
Healthcare Economic Case Study for IRegained MyHand System
Agreement Title (French)
Étude de cas sur l'économie des soins de santé pour le système MyHand d'Iregained
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The IRegained MyHand System is planned to be exported to the USA in Q2 of 2022. In preparation for this market launch, IRegained is completing a health care economics value proposition model and whitepaper to establish a clear reimbursement pathway through the payors such as insurance companies, Medicare, Medicaid etc. for customer adoption.
Description (French)
L'exportation du système MyHand d'IRegained vers les États-Unis est prévue pour le deuxième trimestre de 2022. En préparation de ce lancement sur le marché, IRegained achève un modèle de proposition de valeur économique des soins de santé et un livre blanc pour établir une voie de remboursement claire à travers les payeurs tels que les compagnies d'assurance, Medicare, Medicaid, etc. aux fins d'adoption par les clients.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Sudbury
Federal Riding (French)
Sudbury
Federal Riding Number
35103
NAICS Code
54171
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
737051524
Recipient City
Sudbury|Sudbury
Recipient Country
CA
Recipient Legal Name
IRegained Inc.
Recipient Postal Code
P3A 4R7
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2021-2022-Q1-971563